[go: up one dir, main page]

WO2002017928A3 - Transdermales therapeutisches system zur abgabe von exemestan - Google Patents

Transdermales therapeutisches system zur abgabe von exemestan Download PDF

Info

Publication number
WO2002017928A3
WO2002017928A3 PCT/EP2001/009530 EP0109530W WO0217928A3 WO 2002017928 A3 WO2002017928 A3 WO 2002017928A3 EP 0109530 W EP0109530 W EP 0109530W WO 0217928 A3 WO0217928 A3 WO 0217928A3
Authority
WO
WIPO (PCT)
Prior art keywords
active agent
exemestane
transdermal therapeutic
therapeutic system
releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/009530
Other languages
English (en)
French (fr)
Other versions
WO2002017928A2 (de
Inventor
Thorsten Selzer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of WO2002017928A2 publication Critical patent/WO2002017928A2/de
Publication of WO2002017928A3 publication Critical patent/WO2002017928A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ein transdermales therapeutisches System in Pflasterform zur Verabreichung des Wirkstoffs Exemestan oder eines anderen Wirkstoffs aus der Gruppe der Aromatase-Hemmer, weist eine wirkstoffundurchlässige Rückschicht, ein damit verbundenes Wirkstoffreservoir, das den Wirkstoff Exemestan und/oder einen anderen Wirkstoff aus der Gruppe der Aromatase-Hemmer enthält, eine hautseitige haftklebende Schicht und eine vor der Applikation ablösbare wirkstoffundurchlässige Schutzschicht auf.
PCT/EP2001/009530 2000-08-30 2001-08-18 Transdermales therapeutisches system zur abgabe von exemestan Ceased WO2002017928A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10042411.2 2000-08-30
DE2000142411 DE10042411A1 (de) 2000-08-30 2000-08-30 Transdermales therapeutisches System zur Abgabe von Exemestan

Publications (2)

Publication Number Publication Date
WO2002017928A2 WO2002017928A2 (de) 2002-03-07
WO2002017928A3 true WO2002017928A3 (de) 2002-06-27

Family

ID=7654181

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/009530 Ceased WO2002017928A2 (de) 2000-08-30 2001-08-18 Transdermales therapeutisches system zur abgabe von exemestan

Country Status (2)

Country Link
DE (1) DE10042411A1 (de)
WO (1) WO2002017928A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
DE102007032468A1 (de) * 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
DE102010046464A1 (de) 2009-03-19 2011-04-21 Amw Gmbh Transdermales System mit Aromatasehemmer
DE102010026883A1 (de) 2010-03-11 2011-12-15 Amw Gmbh Transdermales System mit Aromatasehemmer
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
DE102019201431A1 (de) 2019-02-05 2020-08-06 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit Feststoffreservoir
DE102019201430A1 (de) 2019-02-05 2020-08-06 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System (TTS) mit Transportmedium
DE102019110397A1 (de) * 2019-04-18 2020-10-22 Amw Gmbh Transdermales Darreichungssystem mit Aromatasehemmer in übersättigter Matrix
DE102019110398A1 (de) * 2019-04-18 2020-10-22 Amw Gmbh Transdermales Darreichungssystem mit Aromatasehemmer

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019746A1 (en) * 1992-04-03 1993-10-14 Orion-Yhtymä Oy Topical administration of toremifene and its metabolites
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
WO2000043553A1 (en) * 1999-01-26 2000-07-27 Pro-Duct Health, Inc. Identifying, monitoring, and treating women for breast precancer or cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
US5567831A (en) * 1995-08-16 1996-10-22 Duguesne University Of The Holy Ghost Non-steroidal sulfatase inhibitor compounds and their method of use

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019746A1 (en) * 1992-04-03 1993-10-14 Orion-Yhtymä Oy Topical administration of toremifene and its metabolites
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
WO1997029735A1 (en) * 1996-02-19 1997-08-21 Monash University Dermal penetration enhancers and drug delivery systems involving same
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
WO2000043553A1 (en) * 1999-01-26 2000-07-27 Pro-Duct Health, Inc. Identifying, monitoring, and treating women for breast precancer or cancer

Also Published As

Publication number Publication date
WO2002017928A2 (de) 2002-03-07
DE10042411A1 (de) 2002-03-28

Similar Documents

Publication Publication Date Title
TW570815B (en) Transdermal therapeutic system (TTS) containing the active substance fentanyl
DK0697860T3 (da) Estradiolholdigt transdermalt terapeutisk system
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
WO2004054638A3 (en) Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
WO2008049516A3 (de) Transdermales therapeutisches system enthaltend norelgestromin zur kontrazeption und hormonsubstitution
NO974878D0 (no) Kroppsheftende sanitetsprodukt
NZ541807A (en) UV stable transdermal therapeutic plaster
IL181337A0 (en) Transdermal therapeutic system comprising an adhesive layer, method for siliconizing the back layer of the system and use of said back layer
MY132338A (en) Estradiol-containing patch
NO992674D0 (no) Konturen til et transdermalt terapeutisk system
DE50212336D1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
WO2002017928A3 (de) Transdermales therapeutisches system zur abgabe von exemestan
HU9500729D0 (en) Dexpanthenol-containing plaster for the transdermal application of steroid hormones
WO1997004818A3 (de) Transdermales therapeutisches system zur abgabe von wirkstoffen über die haut an den menschlichen körper
MX2009008993A (es) Dispositivo para la administracion percutanea de bisoprolol.
WO2005082428A3 (de) Pflaster mit reduzierter hautirritation
MXPA02009103A (es) Sistema terapeutico transdermal para la administracion de lerisetron.
WO2002022109A3 (en) Patch comprising diclofenac
IL92924A0 (en) Superficial therapeutic system comprising an antineoplastic active substance
DK0680319T3 (da) Nitroglycerin-holdigt plaster, fremgangsmåde til dets fremstilling og anvendelse heraf.
HUP0003347A3 (en) Transdermal therapy system (tts) for releasing an active agent and method for applying said transdermal therapy system to the skin
WO2001089511A3 (de) Acetylsalicylsäure enthaltendes superfizielles therapeutisches system zur behandlung von hautschmerzen
HUP0003476A2 (hu) Eljárás transzdermális gyógyászati rendszer helytelen orális alkalmazásának megelőzésére és denaturáló anyagot tartalmazó transzdermális gyógyászati rendszer
WO2001041771A3 (de) Acetylsalicylsäure enthaltendes transdermales system zur behandlung von migräne
TR200102732T2 (tr) Deriye nüfuzlu tedavi sistemi ve üretim yöntemi

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP KR US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP KR US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP